PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast

By PVI, PeerView Institute for Medical Education

PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it publishes.

  1. 1.
    "Susana Banerjee, MBBS, MA, FRCP, PhD / William J. Gradishar, MD, FASCO, FACP / Maha Hussain, MD, FACP, FASCO
  2. 2.
    Elizabeth A. Thiele, MD, PhD - Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
  3. 3.
    Kurt A. Schalper, MD, PhD / Shanu Modi, MD - HER2 and HER3 Alterations as Therapeutic Targets of Increasing Significance in Solid Tumors: Implications for Pathology and Oncology Practice
  4. 4.
    Matthew S. Johnson, MD, FSIR / Richard S. Finn, MD - At the Nexus of Locoregional and Systemic Liver Cancer Therapy: A Multidisciplinary Tumor Board on Improving Outcomes in Intermediate to Advanced HCC
  5. 5.
    Daniel J. Lovell, MD, MPH - Addressing the Burden of Polyarticular Juvenile Idiopathic Arthritis: A Roadmap to Improving Early Diagnosis and Treatment to Maximize Long-Term Outcomes
  6. 6.
    Benjamin W. Friedman, MD, MS, FAAEM, FACEP, FAHS - A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
  7. 7.
    Crystal M. Proud, MD - Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
  8. 8.
    Michael R. Bishop, MD - Betting on CAR-T Cell Therapy: Expert Perspectives on Effective Integration Strategies and Achieving Improved Outcomes Across Hematologic Cancers
  1. 9.
    Karl E. Anderson, MD - Acute Hepatic Porphyria: Disease Diagnosis and Revelations Regarding the Role of siRNA Therapy
  2. 10.
    Dara L. Aisner, MD, PhD / Joshua Bauml, MD / Paul A. VanderLaan, MD, PhD - Precision Decisions in Genomic Testing and Targeted Treatment of NSCLC
  3. 11.
    Naval Daver, MD - Optimizing Care for High-Risk Myeloid Cancers: Interprofessional Team Insights From a Center of Excellence
  4. 12.
    Jennifer Wargo, MD, MMSc - The Path Forward for Immunotherapy in Resectable Melanoma: Principles and Perspectives on Using Immune-Based Adjuvant and Neoadjuvant Therapy
  5. 13.
    Brian I. Rini, MD, FASCO - Optimizing Patient Outcomes in RCC Through Safe and Efficacious Use of Immuno-Oncology and Targeted Approaches: Teaming Up to Mitigate and Manage Adverse Events and Maximize Survival
  6. 14.
    Brett King, MD, PhD - Addressing the Unmet Needs of Patients With Moderate to Severe Alopecia Areata: A Visual Exploration of Disease Pathogenesis and the Clinical Potential of Novel Therapeutic Options
  7. 15.
    Hossein Borghaei, DO, MS / Sanjay Mukhopadhyay, MD / Jonathan A. Nowak, MD, PhD - The Nuances of Immunotherapy Biomarker Testing in Solid Tumors: Unraveling Complexities and Overcoming Challenges to Improve Outcomes
  8. 16.
    April W. Armstrong, MD, MPH - Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life
  9. 17.
    Jay B. Wish, MD - Targeting Hypoxia-Inducible Factor Stabilization as a Treatment for Anemia in Chronic Kidney Disease: Examining the Current State of the Science
  10. 18.
    John M. Pagel, MD, PhD / Ian W. Flinn, MD, Ph - DConversations on the New Wave of Innovative Therapy in Follicular Lymphoma: Implications for Personalized Medicine
  11. 19.
    Jay H. Shubrook, DO, FAAFP, FACOFP - Partnering With Peers and Patients: Achieving T2DM Treatment Goals With GLP-1 RA Therapy
  12. 20.
    Alexander (Ander) Cohen, MB BS (Hons), MSc, MD, FRACP, FESC - New Insights: How Does Real-World Evidence Influence VTE Management? A Visual Exploration of Real-World Studies of DOACs
  13. 21.
    Edward J. Fox, MD, PhD - A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
  14. 22.
    Marwan Sabbagh, MD, FAAN, CCRI - Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
  15. 23.
    Kristina M. Deligiannidis, MD - Test Your Knowledge: The Evidence for GABA-Modulating Neuroactive Steroids as a New Class of Rapid-Acting Antidepressants
  16. 24.
    John J. Russell, MD - Rewriting the Rules for Early Cancer Screening: Case-Based Insight on Primary Care Principles for Using Blood-Based Screening Techniques
  17. 25.
    Minetta C. Liu, MD - Innovative Blood-Based Screening in Cancer Care: State of the Science and Future Opportunities for Accelerating Cancer Diagnoses
  18. 26.
    Roy S. Herbst, MD, PhD & Lecia V. Sequist, MD, MPH - New Milestones and Changing Standards of Care in EGFR-Mutated NSCLC: Expanding the Benefits of Genomic Testing and EGFR-Targeted Therapy to Early-Stage Lung Cancer
  19. 27.
    Khaldoun G. Tarakji, MD, MPH - Adopting Telemedicine and Digital Tools for Nonvalvular Atrial Fibrillation Management and Stroke Prevention
  20. 28.
    Toni K. Choueiri, MD - RCC MasterClass and Clinical Consult: Remodeling the Treatment Algorithm With Novel Immune and Targeted Therapies
  21. 29.
    Professor Thomas Powles, MBBS, MRCP, MD - Examining the State of the Science on New Therapies in Bladder Cancer: Perspectives on the Latest Developments Across the Disease Continuum
  22. 30.
    "Corey Cutler, MD, MPH, FRCP(C) & Miguel-Angel Perales, MD - New Perspectives in Acute and Chronic GVHD: Challenges and Opportunities for Improving Prophylaxis and Treatment With Novel Therapeutics"
  23. 31.
    Philip J. Mease, MD, MACR - IL-17 Inhibitors in Nonradiographic Axial Spondyloarthritis: Expert Insight on Clinical Decision-Making in an Expanding Therapeutic Landscape
  24. 32.
    Ruben A. Mesa, MD, FACP / Jeanne M. Palmer, MD - How to Manage JAK Inhibition in Patients Undergoing HCT: Applying the Latest Clinical Evidence to Improve Patient Outcomes in Myelofibrosis
  25. 33.
    Stella Lee, MD - Improving the Management of Chronic Rhinosinusitis With Nasal Polyps: Practical Strategies for Selecting the Right Patients for Targeted Treatment
  26. 34.
    Jason J. Luke, MD, FACP - Expanding the Benefits of Immuno-Oncology to More Patients With Solid Tumors Through Novel Rational Targets and Combinations
  27. 35.
    Rishi P. Singh, MD - Taking an Individualized Approach to Neovascular Age-Related Macular Degeneration: Examining the Evidence to Improve Patient Outcomes
  28. 36.
    Richard S. Finn, MD - How I Think, How I Treat: Remodeling the HCC Treatment Algorithm With New and Emerging Monotherapy, Combination, and Multimodal Approaches
  29. 37.
    Jennifer I. Lim, MD, FARVO - A Quick Look at Recent Evidence for Improving Outcomes in Patients With Diabetic Retinopathy Using Anti-VEGF Therapy
  30. 38.
    Stephen V. Liu, MD - Changing the Game for Patients With ES-SCLC Through Multidisciplinary Collaboration: Best Practices to Optimize Immunotherapy-Based Approaches and Improve Patient Outcomes
  31. 39.
    Robert Z. Orlowski, MD, PhD / Nina Shah, MD - The Multiple Myeloma Workshop: Exploring the Convergence of Novel Therapeutic Platforms, Cell Therapy, and ASCT
  32. 40.
    Milind Javle, MD - A New Dawn in the Therapeutic Management of Biliary Cancers: Integrating Precision Medicine With New and Emerging Targeted Strategies
  33. 41.
    Reynold A. Panettieri, Jr., MD - Improving Adherence to Evidence-Based Guidelines for the Diagnosis and Management of COPD: Practical Strategies for the Healthcare Team to Optimize Patient Care
  34. 42.
    Axel Grothey, MD - Taking Aim at GI Cancers: New Opportunities to Deliver Personalized Treatment With HER2 and Other Molecularly Targeted Therapies
  35. 43.
    Manish A. Shah, MD, FASCO - Checkpoint Inhibition in Gastrointestinal Cancers: Recent Advances in Gastric, Esophageal, and Colorectal Cancers and Their Application in Clinical Practice
  36. 44.
    Jacob Sands, MD - Selective Inhibition of Oncogenic Transcription and Other Novel Approaches in the Treatment of Small Cell Lung Cancer: An Illustrative Guide to Navigating the Evolving Treatment Landscape and Integrating Latest Treatment Modalities Into Clinical Care
  37. 45.
    Anne H. Cross, MD, FAAN / Prof. Xavier Montalban - Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
  38. 46.
    Professor Kausik Ray - Mastering the Management of Hyperlipidemia in Statin-Treated or Statin-Intolerant Patients: Recent Treatment Advances for Patients That Remain at High Risk of ASCVD
  39. 47.
    Steven Brem, MD - Rethinking Glioblastoma Care in an Evolving Therapeutic Landscape: Expert Perspectives on Modern Modalities, Novel Agents, and Combinations
  40. 48.
    Maria Arcila, MD / Zofia Piotrowska, MD - New Horizons in EGFR-Mutated NSCLC: Broadening the Impact of Precision Testing in the Context of an Expanding Treatment Landscape
  41. 49.
    Mark Crowther, MD, MSc, FRCPC, FRSC - Managing Bleeding Events in Patients Receiving Direct Oral Anticoagulants: When Is It Appropriate to Implement Reversal Strategies in Patients With GI Bleeding?
  42. 50.
    Maria K. Houtchens, MD, MMs - MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies

Listen to PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast now.

Listen to PeerView Clinical Pharmacology CME/CNE/CPE Audio Podcast in full in the Spotify app